| |
| |
|
| Insider
Information: |
Popovits Kimberly J |
| Relationship: |
|
| City: |
Sunnyvale |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
35,386 |
|
|
Indirect Shares
|
182,025 |
|
|
| Direct
Value |
$92,850 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
217,411 |
|
|
| Total
Value |
$92,850 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Genomic Health Inc |
GHDX |
President and CEO, Dir... |
2019-11-08 |
0 |
2019-11-08 |
0 |
Premium* |
|
|
Zs Pharma, Inc. |
ZSPH |
Director |
2015-12-17 |
0 |
2015-12-17 |
0 |
Premium* |
|
|
Talis Biomedical Corp |
TLIS |
Director |
2021-02-17 |
25,776 |
2021-02-17 |
182,025 |
Premium* |
|
|
10x Genomics, Inc. |
TXG |
|
2023-06-14 |
4,610 |
2021-06-11 |
0 |
Premium* |
|
|
Kiniksa Pharmaceuticals, Ltd. |
KNSA |
|
2023-06-29 |
5,000 |
2023-06-29 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TLIS |
Talis Biomedical Corp |
Director |
– • – |
2021-02-17 |
4 |
A |
$0.00 |
$0 |
I/I |
391,815 |
182,025 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
President and CEO |
• • – |
2011-02-25 |
4/A |
GA |
$0.00 |
$0 |
I/I |
284,363 |
283,292 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
President and CEO |
• • – |
2011-02-25 |
4/A |
GD |
$0.00 |
$0 |
D/D |
284,363 |
10,000 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
President and CEO |
• • – |
2019-11-08 |
4 |
D |
$0.00 |
$0 |
I/I |
(80,566) |
0 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
President and COO |
• • – |
2005-08-31 |
4 |
OE |
$0.66 |
$49,500 |
D/D |
75,000 |
333,333 |
|
- |
|
| GHDX |
Genomic Health Inc |
President and CEO |
• • – |
2018-08-14 |
4 |
AS |
$51.92 |
$3,156,203 |
I/I |
(60,000) |
176,982 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
President and CEO |
• • – |
2019-02-14 |
4 |
AS |
$81.46 |
$3,913,615 |
I/I |
(47,900) |
116,982 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
President and CEO |
• • – |
2019-02-14 |
4 |
OE |
$17.18 |
$822,922 |
I/I |
47,900 |
164,882 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
President & COO |
• • – |
2007-04-30 |
4 |
OE |
$0.63 |
$27,502 |
D/D |
43,345 |
390,161 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
President and CEO |
• • – |
2019-11-08 |
4 |
D |
$0.00 |
$0 |
D/D |
(36,168) |
0 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
President and CEO |
• • – |
2017-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
27,760 |
87,380 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
President and CEO |
• • – |
2016-02-16 |
4 |
A |
$0.00 |
$0 |
D/D |
26,300 |
58,796 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
President and CEO |
• • – |
2018-10-15 |
4 |
OE |
$22.98 |
$574,500 |
I/I |
25,000 |
201,982 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
President and CEO |
• • – |
2018-10-15 |
4 |
AS |
$64.26 |
$1,607,641 |
I/I |
(25,000) |
176,982 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
President and CEO |
• • – |
2018-10-16 |
4 |
OE |
$22.98 |
$574,500 |
I/I |
25,000 |
201,982 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
President and CEO |
• • – |
2018-10-16 |
4 |
AS |
$64.45 |
$1,656,524 |
I/I |
(25,000) |
176,982 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
President and CEO |
• • – |
2018-11-15 |
4 |
AS |
$74.77 |
$1,929,560 |
I/I |
(25,000) |
176,982 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
President and CEO |
• • – |
2018-11-15 |
4 |
OE |
$22.98 |
$574,500 |
I/I |
25,000 |
201,982 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
President and CEO |
• • – |
2018-12-17 |
4 |
AS |
$65.85 |
$1,672,242 |
I/I |
(25,000) |
141,982 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
President and CEO |
• • – |
2018-12-18 |
4 |
AS |
$65.79 |
$1,667,285 |
I/I |
(25,000) |
116,982 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
President and CEO |
• • – |
2019-08-08 |
4 |
AS |
$73.63 |
$1,846,266 |
I/I |
(25,000) |
108,468 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
President and CEO |
• • – |
2019-08-08 |
4 |
OE |
$29.34 |
$733,500 |
I/I |
25,000 |
133,468 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
President and CEO |
• • – |
2019-08-09 |
4 |
AS |
$73.63 |
$1,841,542 |
I/I |
(25,000) |
108,468 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
President and CEO |
• • – |
2019-08-09 |
4 |
OE |
$29.34 |
$733,500 |
I/I |
25,000 |
133,468 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
President and CEO |
• • – |
2019-08-12 |
4 |
OE |
$29.34 |
$733,500 |
I/I |
25,000 |
133,468 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
